Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Shares Outstanding (Weighted Average) (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Shares Outstanding (Weighted Average) for 4 consecutive years, with $2.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 340.53% to $2.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.2 million, a 340.53% increase, with the full-year FY2024 number at $454582.0, up 585.5% from a year prior.
  • Shares Outstanding (Weighted Average) was $2.2 million for Q3 2025 at 60 Degrees Pharmaceuticals, up from $1.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $2.4 million in Q4 2022 to a low of $66314.0 in Q4 2023.
  • A 4-year average of $1.2 million and a median of $886058.0 in 2024 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): crashed 97.2% in 2023, then skyrocketed 660.54% in 2025.
  • 60 Degrees Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $2.4 million in 2022, then plummeted by 97.2% to $66314.0 in 2023, then soared by 585.5% to $454582.0 in 2024, then skyrocketed by 373.55% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Shares Outstanding (Weighted Average) are $2.2 million (Q3 2025), $1.5 million (Q2 2025), and $1.3 million (Q1 2025).